Lazari Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Sell |
11,546
-2,809
| -20% | -$47.1K | 0.07% | 142 |
|
|
2025
Q1 | $221K | Sell |
14,355
-153
| -1% | -$2.35K | 0.09% | 129 |
|
|
2024
Q4 | $320K | Sell |
14,508
-1,102
| -7% | -$24.3K | 0.13% | 94 |
|
|
2024
Q3 | $281K | Hold |
15,610
| – | – | 0.12% | 110 |
|
|
2024
Q2 | $254K | Sell |
15,610
-120
| -0.8% | -$1.95K | 0.11% | 107 |
|
|
2024
Q1 | $222K | Sell |
15,730
-500
| -3% | -$7.06K | 0.12% | 98 |
|
|
2023
Q4 | $169K | Sell |
16,230
-900
| -5% | -$9.4K | 0.1% | 109 |
|
|
2023
Q3 | $175K | Sell |
17,130
-1,200
| -7% | -$12.2K | 0.1% | 105 |
|
|
2023
Q2 | $138K | Buy |
+18,330
| New | +$138K | 0.08% | 115 |
|